Asia Standardization of Molecular Analyses; Current status & Validation plan | ||
---|---|---|
Chairperson: Prof. Dong-Wook Kim (Seoul, Korea) | ||
09:00 | Welcome and introduction | DW Kim (Seoul, Korea) |
09:10 | Update of ASMA training program and Questionnaire | H Goh (Seoul, Korea) |
09:30 | Current status of BCR-ABL molecular assays in Asian Lab (multiplex PCR/Q-PCR/mutation test) China/India/Indonesia/Phillippine/Taiwan/Thailand (10 minutes each) |
Trainees (Asia countries) |
10:30 | Update of International Standardization of RQ-PCR testing | H Goh (Seoul, Korea) |
10:40 | Tea break | |
11:00 | Asia PCR kits: Technology and Standardization | JH Park (Bioneer co., Korea) |
11:15 | Validation plans for RQ-PCR standardization in Asia | H Goh (Seoul, Korea) |
11:30 | Asia Mutation Bank: A proposal for retrospective and prospective mutation studies |
DW Kim (Seoul, Korea) |
11:40 | Current technologies & Validation plans of mutation test in Asia | D Kim (Seoul, Korea) |
12:10 | Discussion: Summary and Next steps | H Goh & D Kim (Seoul, Korea) |
12:30 | Lunch | |
Asia Standardization of Clinical Practice: CML survey & Treatment guideline | ||
Chairperson: Dr. Tapan Saikia (Mumbai, India) | ||
13:30 | Current status of Asia CML Registry | D Kim (Seoul, Korea) |
13:45 | Review of CML manuscripts from Asia | W Cui (Jilin, China) |
14:15 | A proposal of Asia epidemiology study : Based on current Asia survey and its characteristics |
DW Kim (Seoul, Korea) |
14:30 | Development of ACSA-NCCN collaborative programs | EMD-Asia (Singapore) |
14:45 | Introduction and Future plan of NCCN Asia guideline | Tapan Saikia (Mumbai, India) |
15:15 | Discussion: Q & A | All participants |
15:30 | Closing | DW Kim (Seoul, Korea) |
Organizer: Asia CML Foundation,
Asia CML Study Alliance, Korea Leukemia Bank Sponser: Bioneer co., Bristol Myers Squibb co., ILYANG co., Novartis co. |